The drug discovery process is more complex than ever. In our latest poll, we asked what you find to be the greatest challenge you face for #clinicaltrials. Increasing trial complexity was 1 of the top 2 answers. Trust MERIT's tenured specialists to provide robust, personalized service and to proactively manage the imaging requirements of your study. Learn more: https://lnkd.in/dWkJRyMu #MERITCRO #YourClinicalEndpointExpert #ophthalmology #oncology
MERIT CRO’s Post
More Relevant Posts
-
Join my colleagues from Inizio Medical for a webinar on June 27th where we will dive into the most talked-about topics from #ASCO24, provide in-depth analysis, and highlight key takeaways - this is not to be missed! Learn more and register here: https://lnkd.in/e3pr9aEG #MRX #ResearchPartnership #Oncology #Webinar
-
-
It's a wrap - highlights from ASCO 2024. What caught your eye? Check out my blog post https://wix.to/vs1uHiT #ASCO2024 #EyesOnPharma #PharmaTell #Oncology #MedicalConferences
-
Cut prep time and increase tumor board efficiency! See how datma streamlines data collection, case presentations, and collaboration for more productive tumor boards. Calculate your potential time & cost savings either our new ROI calculator www.datma.com/roi #tumorboard #oncology #precisionmedicine
-
-
Working towards a better understanding of immuno-oncology? Listen to this chat of a panel of scientists who are researching towards understanding CAR-T therapy patient factors. Watch on-demand now: https://ow.ly/NqOq50QtoNt #flowcytometry #oncology #EmoryMedicine #immunooncology
-
Enhance your Molecular Tumor Board with datma.360 visualization tool that augments your EHR, integrating fragmented healthcare data (including omics, clinical and imaging data) that currently impedes comprehensive patient analysis. This facilitates actionable insights for personalized medicine and helps prevent gaps in patient care. Revolutionize how you manage complex molecular diagnostic data in oncology and experience the future of precision medicine with Molecular Tumor Boards powered by datma.360. Reach out for a demo today! #oncology #precisionmedicine #ai #healthcareinnovation #moleculartumorboards #genomics #tumorboard #datma
Cut prep time and increase tumor board efficiency! See how datma streamlines data collection, case presentations, and collaboration for more productive tumor boards. Calculate your potential time & cost savings either our new ROI calculator www.datma.com/roi #tumorboard #oncology #precisionmedicine
-
-
Receive expert guidance on the evolving role of adjuvant CDK4/6 inhibition to help patients with HR+ early #BreastCancer derive maximum benefit in a new #MedEd activity with @DrAdityaBardia developed with partners @PeerView & @LivingBeyondBC: https://bit.ly/3wEdLgX #Oncology
-
-
Learn from #RECIST expert, Dr. Oliver Bohnsack how response evaluation in #Oncology research can be improved – and in many cases, fewer #ClinicalTrial patients lost – by using #irRECIST to assess tumor burden. https://lnkd.in/gG7Bgt5a #MedicalImaging #ClinicalTrials #ChooseCalyx
-
Learn from #RECIST expert, Dr. Oliver Bohnsack how response evaluation in #Oncology research can be improved – and in many cases, fewer #ClinicalTrial patients lost – by using #irRECIST to assess tumor burden. https://lnkd.in/gS4eKZP8 #MedicalImaging #ClinicalTrials #ChooseCalyx
-
ELCC 2024 wrapped up over the weekend and we’ve compiled the latest post-conference insights, highlighting the top trials as discussed by leading oncologists on X. 🌟 Learn more about LARVOL CLIN and explore our key insights here: https://bit.ly/3TTUFwc. #ELCC2024 #LARVOL #Oncology #Research
-
-
Learn from #RECIST expert, Dr. Oliver Bohnsack how response evaluation in #Oncology research can be improved – and in many cases, fewer #ClinicalTrial patients lost – by using #irRECIST to assess tumor burden. https://lnkd.in/gB39hPd7 #MedicalImaging #ClinicalTrials #ChooseCalyx
